Open | $1.320 |
Close | $1.390 |
Volume / Avg. | 28.006K / 474.364K |
Day Range | 1.310 - 1.430 |
52 Wk Range | 1.200 - 7.130 |
Market Cap | $9.180M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 1.3% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BioRestorative Therapies (NASDAQ: BRTX) through any online brokerage.
Other companies in BioRestorative Therapies’s space includes: Imunon (NASDAQ:IMNN), Monopar Therapeutics (NASDAQ:MNPR), NexImmune (NASDAQ:NEXI), Longeveron (NASDAQ:LGVN) and Portage Biotech (NASDAQ:PRTG).
The latest price target for BioRestorative Therapies (NASDAQ: BRTX) was reported by Roth MKM on Monday, August 14, 2023. The analyst firm set a price target for 15.00 expecting BRTX to rise to within 12 months (a possible 971.43% upside). 1 analyst firms have reported ratings in the last year.
The stock price for BioRestorative Therapies (NASDAQ: BRTX) is $1.4 last updated March 18, 2024 at 4:45 PM EDT.
There are no upcoming dividends for BioRestorative Therapies.
BioRestorative Therapies’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for BioRestorative Therapies.
BioRestorative Therapies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.